A detailed history of Capital Analysts, LLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Capital Analysts, LLC holds 43 shares of ZBH stock, worth $4,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 43 -0.0%
Holding current value
$4,661
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$104.7 - $128.4 $104 - $128
1 Added 2.38%
43 $5,000
Q4 2021

Feb 10, 2022

SELL
$115.43 - $146.63 $10,504 - $13,343
-91 Reduced 68.42%
42 $5,000
Q3 2021

Nov 04, 2021

BUY
$136.35 - $158.76 $12,407 - $14,447
91 Added 216.67%
133 $19,000
Q2 2021

Nov 15, 2021

SELL
$152.95 - $173.41 $3,059 - $3,468
-20 Reduced 32.26%
42 $7,000
Q2 2021

Aug 05, 2021

SELL
$152.95 - $173.41 $10,859 - $12,312
-71 Reduced 53.38%
62 $10,000
Q1 2021

May 17, 2021

BUY
$148.16 - $159.71 $19,705 - $21,241
133 New
133 $22,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.